Breakthrough designation for Treatment of Non-Muscle Invasive Bladder Cancer (NMIBC) supports CAPS Medical's mission to transform tumor ablation into a simple, selective, and in-office procedure SANTA MONICA, Calif. and NETANYA, Israel, Oct. 15, 2025 /PRNewswire/ -- CAPS Medical, a...
CAPS Medical's PlasmaSure™ Receives FDA Breakthrough Device Designation
Seeking Alpha / 19 hours ago 2 Views
Comments